75N93023F00001

THE TASK ORDER IS TO SUPPORT CGMP MANUFACTURING OF THE PGT121.414.LS MONOCLONAL ANTIBODY (PGT121.414.LS MAB) DRUG SUBSTANCE FROM AN ESTABLISHED MANUFACTURING PROCESS, COMPLETE THE FILL FINISH OF THE DRUG SUBSTANCE (DS) INTO DRUG PRODUCT (DP), QUALITY

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	NATIONAL INSTITUTES OF HEALTH NIAID
NAICS	541712
PSC	AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle	HHSN272201700010I
Set-aside	Not reported
Pricing type	COST PLUS FIXED FEE
Obligations	$17.2M
Current contract value	$17.2M
Potential contract value / ceiling	$17.2M
Start date	Jun 10, 2017
Current end date	Dec 30, 2028
Potential end date	Dec 30, 2028
Latest award activity	Jun 17, 2026
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Jun 17, 2026	P00004	$0	CGMP MANUFACTURING OF PGT121.414.LS MAB - NIAID PRECLINICAL DEVELOPMENT SUPPORT EOI::EO:RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING
Sep 30, 2025	P00003	$-1.5M	CGMP MANUFACTURING OF PGT121.414.LS MAB - NIAID PRECLINICAL DEVELOPMENT SUPPORT EOI::EO:RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING
May 15, 2024	P00002	$188.4K	CGMP MANUFACTURING OF PGT121.414.LS MAB - NIAID PRECLINICAL DEVELOPMENT SUPPORT
Oct 26, 2023	P00001	$3.2M	CGMP MANUFACTURING OF PGT121.414.LS MAB - NIAID PRECLINICAL DEVELOPMENT SUPPORT
Aug 23, 2023	0	$15.4M	THE TASK ORDER IS TO SUPPORT CGMP MANUFACTURING OF THE PGT121.414.LS MONOCLONAL ANTIBODY (PGT121.414.LS MAB) DRUG SUBSTANCE FROM AN ESTABLISHED MANUFACTURING PROCESS, COMPLETE THE FILL FINISH OF THE DRUG SUBSTANCE (DS) INTO DRUG PRODUCT (DP), QUALITY

Estimated positioning window

Dec 30, 2027 – Jun 30, 2028

Recompete signal:

55/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 55/100. Available recorded signals: 50 points.

Contract end 2028-12-30 (797 days from calculation): +15 points
31 historical awards in this buyer and category group: +15 points
5 recorded award transactions: +10 points
Latest award action: 2026-06-17: +5 points
Parent award identifier recorded: +5 points
Solicitation identifier recorded: +0 points
Linked official forecast: +0 points
Calculated on: 2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Confirm the ordering vehicle and your eligibility or a qualified teaming route.
Review the award scope and buyer evidence before making a bid/no-bid decision.